Created on : 03.10.2024 Last modified : 03.10.2024

A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland

Switzerland, 2021 - 2022
DDP

Reference ID

10.16909-dataset-54

Producer(s)

GENTON, Blaise

Collections

Department of Ambulatory Care (DDP)